[
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "IL-12",
        "binding_metric": "KOff",
        "value": "0.1",
        "unit": "s^-1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nA series of IC have been obtained <sub>50</sub>The antibody of value in following scope: about 1 * 10 <sup>-6</sup>M is to about 1 * 10 <sup>-11</sup>M, more preferably from about 1 * 10 <sup>-10</sup>M to 1 * 10 <sup>-11</sup>M or lower.\nTherefore, in one aspect, the invention provides such isolating human antibodies or its antigen-binding portion thereof: in conjunction with people IL-12 and with 0.1s <sup>-1</sup>Or with 0.1s <sup>-1</sup>The K that following surface plasmon resonance is measured <sub>Off</sub>Rate constant and people IL-12 dissociate, and perhaps it is with 1 * 10 <sup>-6</sup>M or 1 * 10 <sup>-6</sup>The IC that M is following <sub>50</sub>The phyto"
    },
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "IL-12",
        "binding_metric": "IC50",
        "value": "1 * 10^-6",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nA series of IC have been obtained <sub>50</sub>The antibody of value in following scope: about 1 * 10 <sup>-6</sup>M is to about 1 * 10 <sup>-11</sup>M, more preferably from about 1 * 10 <sup>-10</sup>M to 1 * 10 <sup>-11</sup>M or lower.\nTherefore, in one aspect, the invention provides such isolating human antibodies or its antigen-binding portion thereof: in conjunction with people IL-12 and with 0.1s <sup>-1</sup>Or with 0.1s <sup>-1</sup>The K that following surface plasmon resonance is measured <sub>Off</sub>Rate constant and people IL-12 dissociate, and perhaps it is with 1 * 10 <sup>-6</sup>M or 1 * 10 <sup>-6</sup>The IC that M is following <sub>50</sub>The phyto"
    },
    {
        "molecule_name": "Ustekinumab",
        "protein_target_name": "rhIL-12",
        "binding_metric": "Kd",
        "value": "1.34 * 10^-10",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nJ695 (Kd=1.34 * 10^-10 M) J695 (Kd=9.74 * 10^-11 M)\nTable 8: J695 is to apparent kinetics rate constant and the affinity constant of rhIL-12\n        Antibody    Average association rate (M^-1 S^-1)      Average dissociation speed (S^-1)      Average Kd (M) \n        J695        ?????3.52E+05                          ?????4.72E-05                          ???1.34E-10 \n        J695        ?????3.40E+05                          ?????2.61E-05                          ???9.74E-11 \nTable 10: The kinetic parameter of table 10:J695 and people IL-12 effect\n        Kinetic parameter    Numerical value \n        ???????k_d          ????3.71±0.40×10^-5 s^-1 \n        ???????k_a          ????3.81±0.48×10^5 M^-1s^-1 \n        ???????K_d          ????9.74×10^-11 M \nTable 11: more anti-people IL-12 monoclonal antibody J695 and rat anti-mouse IL-12 mono-clonal\n        Antibody    Epi-position    Biomolecule action is measured    Receptors bind is measured    Ka, association rate (M^-1s^-1)      Kd, dissociation rate (s^-1)      Kd(M)     IC_50(M) \n        J695        ?Hu?p40        ??3.81×10^5                  ????3.71×10^-5                  ?9.47×10^-11                  ???1.1×10^-11                  ????5.8×10^-12 \n        C17.15      ?Mu?p40        ??3.80×10^5                  ????1.84×10^-4                  ?4.80×10^-10                  ???1.5×10^-10                  ????1.4×10^-11 \nDiscovery in this is measured C17.15 to the IC_50 (M) be 1.4 * 10^-11, by contrast, observe under the same conditions J695 to the IC_50 Value is 5.8 * 10^-12"
    },
    {
        "molecule_name": "Ustekinumab",
        "protein_target_name": "rhIL-12",
        "binding_metric": "Kd",
        "value": "9.74 * 10^-11",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nJ695 (Kd=1.34 * 10^-10 M) J695 (Kd=9.74 * 10^-11 M)\nTable 8: J695 is to apparent kinetics rate constant and the affinity constant of rhIL-12\n        Antibody    Average association rate (M^-1 S^-1)      Average dissociation speed (S^-1)      Average Kd (M) \n        J695        ?????3.52E+05                          ?????4.72E-05                          ???1.34E-10 \n        J695        ?????3.40E+05                          ?????2.61E-05                          ???9.74E-11 \nTable 10: The kinetic parameter of table 10:J695 and people IL-12 effect\n        Kinetic parameter    Numerical value \n        ???????k_d          ????3.71±0.40×10^-5 s^-1 \n        ???????k_a          ????3.81±0.48×10^5 M^-1s^-1 \n        ???????K_d          ????9.74×10^-11 M \nTable 11: more anti-people IL-12 monoclonal antibody J695 and rat anti-mouse IL-12 mono-clonal\n        Antibody    Epi-position    Biomolecule action is measured    Receptors bind is measured    Ka, association rate (M^-1s^-1)      Kd, dissociation rate (s^-1)      Kd(M)     IC_50(M) \n        J695        ?Hu?p40        ??3.81×10^5                  ????3.71×10^-5                  ?9.47×10^-11                  ???1.1×10^-11                  ????5.8×10^-12 \n        C17.15      ?Mu?p40        ??3.80×10^5                  ????1.84×10^-4                  ?4.80×10^-10                  ???1.5×10^-10                  ????1.4×10^-11 \nDiscovery in this is measured C17.15 to the IC_50 (M) be 1.4 * 10^-11, by contrast, observe under the same conditions J695 to the IC_50 Value is 5.8 * 10^-12"
    },
    {
        "molecule_name": "Ustekinumab",
        "protein_target_name": "people IL-12",
        "binding_metric": "k_d",
        "value": "3.71±0.40×10^-5",
        "unit": "s^-1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nJ695 (Kd=1.34 * 10^-10 M) J695 (Kd=9.74 * 10^-11 M)\nTable 8: J695 is to apparent kinetics rate constant and the affinity constant of rhIL-12\n        Antibody    Average association rate (M^-1 S^-1)      Average dissociation speed (S^-1)      Average Kd (M) \n        J695        ?????3.52E+05                          ?????4.72E-05                          ???1.34E-10 \n        J695        ?????3.40E+05                          ?????2.61E-05                          ???9.74E-11 \nTable 10: The kinetic parameter of table 10:J695 and people IL-12 effect\n        Kinetic parameter    Numerical value \n        ???????k_d          ????3.71±0.40×10^-5 s^-1 \n        ???????k_a          ????3.81±0.48×10^5 M^-1s^-1 \n        ???????K_d          ????9.74×10^-11 M \nTable 11: more anti-people IL-12 monoclonal antibody J695 and rat anti-mouse IL-12 mono-clonal\n        Antibody    Epi-position    Biomolecule action is measured    Receptors bind is measured    Ka, association rate (M^-1s^-1)      Kd, dissociation rate (s^-1)      Kd(M)     IC_50(M) \n        J695        ?Hu?p40        ??3.81×10^5                  ????3.71×10^-5                  ?9.47×10^-11                  ???1.1×10^-11                  ????5.8×10^-12 \n        C17.15      ?Mu?p40        ??3.80×10^5                  ????1.84×10^-4                  ?4.80×10^-10                  ???1.5×10^-10                  ????1.4×10^-11 \nDiscovery in this is measured C17.15 to the IC_50 (M) be 1.4 * 10^-11, by contrast, observe under the same conditions J695 to the IC_50 Value is 5.8 * 10^-12"
    },
    {
        "molecule_name": "Ustekinumab",
        "protein_target_name": "people IL-12",
        "binding_metric": "k_a",
        "value": "3.81±0.48×10^5",
        "unit": "M^-1s^-1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nJ695 (Kd=1.34 * 10^-10 M) J695 (Kd=9.74 * 10^-11 M)\nTable 8: J695 is to apparent kinetics rate constant and the affinity constant of rhIL-12\n        Antibody    Average association rate (M^-1 S^-1)      Average dissociation speed (S^-1)      Average Kd (M) \n        J695        ?????3.52E+05                          ?????4.72E-05                          ???1.34E-10 \n        J695        ?????3.40E+05                          ?????2.61E-05                          ???9.74E-11 \nTable 10: The kinetic parameter of table 10:J695 and people IL-12 effect\n        Kinetic parameter    Numerical value \n        ???????k_d          ????3.71±0.40×10^-5 s^-1 \n        ???????k_a          ????3.81±0.48×10^5 M^-1s^-1 \n        ???????K_d          ????9.74×10^-11 M \nTable 11: more anti-people IL-12 monoclonal antibody J695 and rat anti-mouse IL-12 mono-clonal\n        Antibody    Epi-position    Biomolecule action is measured    Receptors bind is measured    Ka, association rate (M^-1s^-1)      Kd, dissociation rate (s^-1)      Kd(M)     IC_50(M) \n        J695        ?Hu?p40        ??3.81×10^5                  ????3.71×10^-5                  ?9.47×10^-11                  ???1.1×10^-11                  ????5.8×10^-12 \n        C17.15      ?Mu?p40        ??3.80×10^5                  ????1.84×10^-4                  ?4.80×10^-10                  ???1.5×10^-10                  ????1.4×10^-11 \nDiscovery in this is measured C17.15 to the IC_50 (M) be 1.4 * 10^-11, by contrast, observe under the same conditions J695 to the IC_50 Value is 5.8 * 10^-12"
    },
    {
        "molecule_name": "Ustekinumab",
        "protein_target_name": "people IL-12",
        "binding_metric": "K_d",
        "value": "9.74×10^-11",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nJ695 (Kd=1.34 * 10^-10 M) J695 (Kd=9.74 * 10^-11 M)\nTable 8: J695 is to apparent kinetics rate constant and the affinity constant of rhIL-12\n        Antibody    Average association rate (M^-1 S^-1)      Average dissociation speed (S^-1)      Average Kd (M) \n        J695        ?????3.52E+05                          ?????4.72E-05                          ???1.34E-10 \n        J695        ?????3.40E+05                          ?????2.61E-05                          ???9.74E-11 \nTable 10: The kinetic parameter of table 10:J695 and people IL-12 effect\n        Kinetic parameter    Numerical value \n        ???????k_d          ????3.71±0.40×10^-5 s^-1 \n        ???????k_a          ????3.81±0.48×10^5 M^-1s^-1 \n        ???????K_d          ????9.74×10^-11 M \nTable 11: more anti-people IL-12 monoclonal antibody J695 and rat anti-mouse IL-12 mono-clonal\n        Antibody    Epi-position    Biomolecule action is measured    Receptors bind is measured    Ka, association rate (M^-1s^-1)      Kd, dissociation rate (s^-1)      Kd(M)     IC_50(M) \n        J695        ?Hu?p40        ??3.81×10^5                  ????3.71×10^-5                  ?9.47×10^-11                  ???1.1×10^-11                  ????5.8×10^-12 \n        C17.15      ?Mu?p40        ??3.80×10^5                  ????1.84×10^-4                  ?4.80×10^-10                  ???1.5×10^-10                  ????1.4×10^-11 \nDiscovery in this is measured C17.15 to the IC_50 (M) be 1.4 * 10^-11, by contrast, observe under the same conditions J695 to the IC_50 Value is 5.8 * 10^-12"
    },
    {
        "molecule_name": "anti-IL-12 monoclonal antibody",
        "protein_target_name": "mouse IL-12",
        "binding_metric": "IC50",
        "value": "1.5 * 10^-10",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The result shows that C17.15 suppresses the IC of mouse IL-12 in conjunction with cell receptor <sub>50</sub>(M) be 1.5 * 10 <sup>-10</sup>\n* The association rate that observes recombined small-mouse IL-12-C17.15 effect is 3.8 * 10 <sup>5</sup>M <sup>-1</sup>s <sup>-1</sup>, dissociation rate is 1.84 * 10 <sup>-4</sup>s <sup>-1</sup>, and Kd is 4.8 * 10 <sup>-10</sup>\n* Explanation is according to association rate, dissociation rate, Kd, IC <sub>50</sub> Measure with the PHA parent cell, the binding mode of rat anti-mouse IL-12 antibody C17.15 and anti-people IL-12 antibody J695 much at one."
    },
    {
        "molecule_name": "anti-IL-12 monoclonal antibody",
        "protein_target_name": "recombined small-mouse IL-12",
        "binding_metric": "Kd",
        "value": "4.8 * 10^-10",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The result shows that C17.15 suppresses the IC of mouse IL-12 in conjunction with cell receptor <sub>50</sub>(M) be 1.5 * 10 <sup>-10</sup>\n* The association rate that observes recombined small-mouse IL-12-C17.15 effect is 3.8 * 10 <sup>5</sup>M <sup>-1</sup>s <sup>-1</sup>, dissociation rate is 1.84 * 10 <sup>-4</sup>s <sup>-1</sup>, and Kd is 4.8 * 10 <sup>-10</sup>\n* Explanation is according to association rate, dissociation rate, Kd, IC <sub>50</sub> Measure with the PHA parent cell, the binding mode of rat anti-mouse IL-12 antibody C17.15 and anti-people IL-12 antibody J695 much at one."
    },
    {
        "molecule_name": "ALP 903",
        "protein_target_name": "J695",
        "binding_metric": "Kd",
        "value": "1.19×10^-10",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n1. The calculating K d that ALP is 903 crowdes is 1.19 ± 0.22 * 10^-10 M, and the Kd of 905 crowdes of ALP is 1.49 ± 0.47 * 10^-10 M (seeing Table 13).\n2. **Table 13**: the characteristic that compares the J695 of 905 crowdes of ALP 903 and ALP AntibodyKa, association rate (M^-1，s^-1)                                         Kd, dissociation rate (s^-1)                                         Kd(M)                                        RB measures IC_<sub>50</sub>????(M)                                         The PHA parent cell is measured IC_<sub>50</sub>(M)                                         IFN-γ measures IC_<sub>50</sub>(M)                                         ALP？903                                        J695                                                                            3.75×10^5                                    4.46×10^-5                                    1.19×10^-10                                    3.4×10^-11                                    5.5×10^-12                                    5.8×10^-12                                    ALP？905                                        J695                                                                            3.91×10^5                                    5.59×10^-5                                    1.49×10^-10                                    3.0×10^-11                                    4.4×10^-12 \n\nNote that only the rows from Table 13 that contain specific molecule names (ALP 903 and ALP 905) and relevant bioactivity metrics (Kd, IC50) with numeric values and units are included."
    },
    {
        "molecule_name": "ALP 905",
        "protein_target_name": "J695",
        "binding_metric": "Kd",
        "value": "1.49×10^-10",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n1. The calculating K d that ALP is 903 crowdes is 1.19 ± 0.22 * 10^-10 M, and the Kd of 905 crowdes of ALP is 1.49 ± 0.47 * 10^-10 M (seeing Table 13).\n2. **Table 13**: the characteristic that compares the J695 of 905 crowdes of ALP 903 and ALP AntibodyKa, association rate (M^-1，s^-1)                                         Kd, dissociation rate (s^-1)                                         Kd(M)                                        RB measures IC_<sub>50</sub>????(M)                                         The PHA parent cell is measured IC_<sub>50</sub>(M)                                         IFN-γ measures IC_<sub>50</sub>(M)                                         ALP？903                                        J695                                                                            3.75×10^5                                    4.46×10^-5                                    1.19×10^-10                                    3.4×10^-11                                    5.5×10^-12                                    5.8×10^-12                                    ALP？905                                        J695                                                                            3.91×10^5                                    5.59×10^-5                                    1.49×10^-10                                    3.0×10^-11                                    4.4×10^-12 \n\nNote that only the rows from Table 13 that contain specific molecule names (ALP 903 and ALP 905) and relevant bioactivity metrics (Kd, IC50) with numeric values and units are included."
    }
]